Serum tumour necrosis factor-alpha and transforming growth factor-beta levels in chronic hepatitis C patients are immunomodulated by therapy.
Neuman MG, Benhamou JP, Bourliere M, Ibrahim A, Malkiewicz I, Asselah T, Martinot-Peignoux M, Shear NH, Katz GG, Akremi R, Benali S, Boyer N, Lecomte L, Le Breton V, Le Guludec G, Marcellin P.
Neuman MG, et al. Among authors: marcellin p.
Cytokine. 2002 Jan 21;17(2):108-17. doi: 10.1006/cyto.2001.0997.
Cytokine. 2002.
PMID: 11886178
Clinical Trial.